The June 28, 2004 Federal Register contains the semi-annual regulatory agendas for numerous federal government agencies. The agendas briefly summarize each agency's regulations that are under development or review, and include an estimated timetable and contact information.
| Eff 06/30/04 FR Pub 06/29/04 The Committee for the Implementation of Textile Agreements (CITA) has issued a notice requesting public comments by July 12, 2004 regarding a "commercial availability" petition it received under the U.S.-Caribbean Basin Trade Partnership Act (CBTPA) on behalf of Pressman-Gutman Co., Inc.: The International Trade Administration (ITA) has issued its final results of the antidumping (AD) duty administrative review of bulk aspirin from China for the period of July 1, 2002 through June 30, 2003. In addition, the ITA is revoking the AD duty order with respect to one company. (a) The ITA states that Linyi Sanshan does not qualify for a separate rate; therefore, it is subject to the China-wide rate of 376.67% The House Committee on Ways and Means has issued a press release stating that it informally approved draft legislation to implement the U.S.-Australia free trade agreement (FTA). According to the press release, no amendments were offered to the draft legislation. (Press Release dated 06/23/04, available at http://waysandmeans.house.gov/News.asp?FormMode=print&ID=230) On June 14, 2004, the House of Representatives passed H.J. Res. 97, which approves the renewal for an additional year of import restrictions contained in the Burmese Freedom and Democracy Act of 2003 (Act, Public Law (P.L.) 108-61). On June 24, 2004, the Senate passed H.J. Res. 97 without amendment, clearing the measure for the President. On June 14, 2004, the House of Representatives approved H.R. 4103, the African Growth and Opportunity Act (AGOA) Acceleration Act of 2004 (AGOA III). The Senate subsequently passed H.R. 4103 without amendment on June 24, 2004, clearing the measure for the President. U.S. Customs and Border Protection (CBP) has issued a general notice announcing that, effective June 28, 2004, it is concluding its Paperless Drawback Prototype (prototype). The Food and Drug Administration (FDA) has issued a notice announcing a revised schedule for certain public meetings it is holding this summer in order to receive input from stakeholders on the modernization of its current good manufacturing practices (CGMP) for food. |